Overview

A Study of MG-K10 in Subjects With Asthma

Status:
Not yet recruiting

Trial end date:
2023-07-20

Target enrollment:

Participant gender:

Summary

This study is a phase Ib/II clinical trial conducted in Chinese adult asthmatic subjects to evaluate the preliminary efficacy and safety of MG-K10 humanized monoclonal antibody injection in the treatment of asthma.

Phase:

Phase 1/Phase 2

Details

Lead Sponsor:

Shanghai Mabgeek Biotech.Co.Ltd